drugset / Trial / NCT00213551

Glutamine and Intestinal Protein Metabolism

NCT00213551

Phase 1 Completed 30 enrolled University Hospital, Rouen
RandomizedCrossoverOpen-labelTreatment

Summary

Gut barrier plays a major role in defence of the organism. During catabolic states, like major surgery or inflammation, gut barrier could be altered. It has been reported that preoperative nutritional support may have beneficial effects on clinical outcome in patients with surgery on gastrointestinal tract. Glutamine, which is a conditionally essential amino, have been reported to modulate inflammatory, antioxidant responses and protein metabolism in intestine. In addition, glutamine supply improves clinical outcome in critically ill patients. Antioxidant micronutrients may also have some beneficial effects in intestine by improving antioxidant response and might also regulate protein expression. Nevertheless, effects of glutamine combined to antioxidant micronutrients have not been evaluated. Thus, the aim of this study will be to assess the influence of glutamine and glutamine-antioxidant micronutrients-containing solutions on intestinal response in humans.

Timeline

Start
2004-04
Primary completion
Completion
2008-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Glucose Unknown 0.12 g/kg Other
Subject Glutamine Other / unclassified
Subject glutamine-antioxidants containing solution Unknown

Indications

No indication recorded.